Vincent J. Angotti - Jun 7, 2022 Form 4 Insider Report for ACELRX PHARMACEUTICALS INC (ACRX)

Role
Chief Executive Officer, Director
Signature
/s/ Martha Adler, Attorney-In-Fact
Stock symbol
ACRX
Transactions as of
Jun 7, 2022
Transactions value $
$10,333
Form type
4
Date filed
6/8/2022, 04:06 PM
Previous filing
Mar 4, 2022
Next filing
Feb 8, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACRX Common Stock Purchase $10.3K +46.4K +4.78% $0.22 1.02M Jun 7, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported on Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $0.2187 to $0.2241 on June 7, 2022. The reporting person will provide upon request to the SEC, the issuer or security holder of Issuer, full information regarding the number of shares purchased at each separate price.